277 related articles for article (PubMed ID: 32572964)
1. Irisin deficiency disturbs bone metabolism.
Zhu X; Li X; Wang X; Chen T; Tao F; Liu C; Tu Q; Shen G; Chen JJ
J Cell Physiol; 2021 Jan; 236(1):664-676. PubMed ID: 32572964
[TBL] [Abstract][Full Text] [Related]
2. Role of irisin in androgen-deficient muscle wasting and osteopenia in mice.
Iemura S; Kawao N; Okumoto K; Akagi M; Kaji H
J Bone Miner Metab; 2020 Mar; 38(2):161-171. PubMed ID: 31494773
[TBL] [Abstract][Full Text] [Related]
3. Role of irisin in effects of chronic exercise on muscle and bone in ovariectomized mice.
Kawao N; Iemura S; Kawaguchi M; Mizukami Y; Takafuji Y; Kaji H
J Bone Miner Metab; 2021 Jul; 39(4):547-557. PubMed ID: 33566209
[TBL] [Abstract][Full Text] [Related]
4. Irisin directly stimulates osteoclastogenesis and bone resorption in vitro and in vivo.
Estell EG; Le PT; Vegting Y; Kim H; Wrann C; Bouxsein ML; Nagano K; Baron R; Spiegelman BM; Rosen CJ
Elife; 2020 Aug; 9():. PubMed ID: 32780016
[TBL] [Abstract][Full Text] [Related]
5. The myokine irisin increases cortical bone mass.
Colaianni G; Cuscito C; Mongelli T; Pignataro P; Buccoliero C; Liu P; Lu P; Sartini L; Di Comite M; Mori G; Di Benedetto A; Brunetti G; Yuen T; Sun L; Reseland JE; Colucci S; New MI; Zaidi M; Cinti S; Grano M
Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12157-62. PubMed ID: 26374841
[TBL] [Abstract][Full Text] [Related]
6. Irisin ameliorates age-associated sarcopenia and metabolic dysfunction.
Guo M; Yao J; Li J; Zhang J; Wang D; Zuo H; Zhang Y; Xu B; Zhong Y; Shen F; Lu J; Ding S; Hu C; Xu L; Xiao J; Ma X
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):391-405. PubMed ID: 36510115
[TBL] [Abstract][Full Text] [Related]
7. FNDC5/irisin facilitates muscle-adipose-bone connectivity through ubiquitination-dependent activation of runt-related transcriptional factors RUNX1/2.
He X; Hua Y; Li Q; Zhu W; Pan Y; Yang Y; Li X; Wu M; Wang J; Gan X
J Biol Chem; 2022 Mar; 298(3):101679. PubMed ID: 35124008
[TBL] [Abstract][Full Text] [Related]
8. Progress and Challenges in the Biology of FNDC5 and Irisin.
Maak S; Norheim F; Drevon CA; Erickson HP
Endocr Rev; 2021 Jul; 42(4):436-456. PubMed ID: 33493316
[TBL] [Abstract][Full Text] [Related]
9. Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism.
Zhang J; Valverde P; Zhu X; Murray D; Wu Y; Yu L; Jiang H; Dard MM; Huang J; Xu Z; Tu Q; Chen J
Bone Res; 2017; 5():16056. PubMed ID: 28944087
[TBL] [Abstract][Full Text] [Related]
10. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.
Moreno-Navarrete JM; Ortega F; Serrano M; Guerra E; Pardo G; Tinahones F; Ricart W; Fernández-Real JM
J Clin Endocrinol Metab; 2013 Apr; 98(4):E769-78. PubMed ID: 23436919
[TBL] [Abstract][Full Text] [Related]
11. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.
Huh JY; Panagiotou G; Mougios V; Brinkoetter M; Vamvini MT; Schneider BE; Mantzoros CS
Metabolism; 2012 Dec; 61(12):1725-38. PubMed ID: 23018146
[TBL] [Abstract][Full Text] [Related]
12. Irisin and musculoskeletal health.
Colaianni G; Cinti S; Colucci S; Grano M
Ann N Y Acad Sci; 2017 Aug; 1402(1):5-9. PubMed ID: 28437576
[TBL] [Abstract][Full Text] [Related]
13. SMAD3 negatively regulates serum irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) during exercise.
Tiano JP; Springer DA; Rane SG
J Biol Chem; 2015 Mar; 290(12):7671-84. PubMed ID: 25648888
[TBL] [Abstract][Full Text] [Related]
14. NAD
Li DJ; Sun SJ; Fu JT; Ouyang SX; Zhao QJ; Su L; Ji QX; Sun DY; Zhu JH; Zhang GY; Ma JW; Lan XT; Zhao Y; Tong J; Li GQ; Shen FM; Wang P
Theranostics; 2021; 11(9):4381-4402. PubMed ID: 33754067
[No Abstract] [Full Text] [Related]
15. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.
Kurdiova T; Balaz M; Vician M; Maderova D; Vlcek M; Valkovic L; Srbecky M; Imrich R; Kyselovicova O; Belan V; Jelok I; Wolfrum C; Klimes I; Krssak M; Zemkova E; Gasperikova D; Ukropec J; Ukropcova B
J Physiol; 2014 Mar; 592(5):1091-107. PubMed ID: 24297848
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Irisin Prevents the Reduction of Osteoblast Differentiation Induced by Stimulated Microgravity through Increasing β-Catenin Expression.
Chen Z; Zhang Y; Zhao F; Yin C; Yang C; Wang X; Wu Z; Liang S; Li D; Lin X; Tian Y; Hu L; Li Y; Qian A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070052
[No Abstract] [Full Text] [Related]
17. Circulating irisin levels and muscle FNDC5 mRNA expression are independent of IL-15 levels in mice.
Quinn LS; Anderson BG; Conner JD; Wolden-Hanson T
Endocrine; 2015 Nov; 50(2):368-77. PubMed ID: 25920499
[TBL] [Abstract][Full Text] [Related]
18. Evidence against a beneficial effect of irisin in humans.
Raschke S; Elsen M; Gassenhuber H; Sommerfeld M; Schwahn U; Brockmann B; Jung R; Wisløff U; Tjønna AE; Raastad T; Hallén J; Norheim F; Drevon CA; Romacho T; Eckardt K; Eckel J
PLoS One; 2013; 8(9):e73680. PubMed ID: 24040023
[TBL] [Abstract][Full Text] [Related]
19. Irisin exerts dual effects on browning and adipogenesis of human white adipocytes.
Zhang Y; Xie C; Wang H; Foss RM; Clare M; George EV; Li S; Katz A; Cheng H; Ding Y; Tang D; Reeves WH; Yang LJ
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E530-41. PubMed ID: 27436609
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA AFF4 modulates osteogenic differentiation in BM-MSCs by activating SMAD1/5 pathway through miR-135a-5p/FNDC5/Irisin axis.
Liu C; Liu AS; Zhong D; Wang CG; Yu M; Zhang HW; Xiao H; Liu JH; Zhang J; Yin K
Cell Death Dis; 2021 Jun; 12(7):631. PubMed ID: 34145212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
